| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9170188 | Journal of Cardiac Failure | 2005 | 11 Pages |
Abstract
These studies are Phase III, multicenter, randomized, double-blinded, placebo-controlled trials designed to test the general hypothesis that chronic oral administration of low doses of enoximone can produce beneficial effects in subjects with advanced or ultra-advanced chronic heart failure.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Brian D. MD, Simon F. MD, Marco MD, Arthur M. MD, PhD, Eric MD, J. William PhD, Michael J. MD, Jean-Francois MD, PhD, Craig PhD, Rick PhD, Gwyn Evans, Jennifer V. PhD, Jennifer Stewart, Alastair D. PhD, Ellen B. PhD, David L. PhD, Michael R. MD, PhD,